Skip to main content
. 2022 Feb 1;269(7):3579–3587. doi: 10.1007/s00415-022-10970-x

Table 3.

Plasma biomarkers in DM1 participants

Participant samples GFAP (pg/mL) NF-L (pg/mL) TAU (pg/mL) Aβ 1-42 (pg/mL) Aβ 1-40 (pg/mL) Aβ 1-42/Aβ 1-40 Ratio
#3 99.75 39.08 3.78 51.6 242.7 0.213
#4 70.43 15.54 0.47 48.3 198.0 0.244
#6 61.42 20.84 1.40 58.5 267.3 0.219
#7 52.15 13.69 2.63 16.2 260.7 0.062
#8 92.61 12.80 2.89 42.6 173.1 0.246
#10 113.05 14.77 0.84 54.0 212.1 0.255
#12 N/A N/A N/A 49.5 193.5 0.256
#13 48.50 4.86 1.08 31.2 160.8 0.194
#14 122.42 20.18 3.12 42.0 188.1 0.223
#15 81.50 5.70 1.56 23.1 204.0 0.113
#17 106.17 8.72 1.60 34.5 192.9 0.179
#19 91.99 100.86 1.95 46.5 216.6 0.215
Mean 85.45 23.37 1.94 41.50 209.15 0.20
Median 91.99 14.77 1.60 44.55 201.00 0.22
SD 24.80 27.35 1.04 12.85 32.99 0.06
1st quartile 65.92 10.76 1.24 33.68 191.70 0.19
Last quartile 99.39 20.51 2.29 48.60 213.23 0.24

For reference, median plasma values of ten healthy donors indicated in the data sheet of the kit were: 8.58 pg/mL for Nf-L, 64.2 pg/mL for GFAP and 2.31 pg/mL for total-Tau, respectively